Pediatric Imaging

How Should You Image a Child’s Vascular Anomaly That Isn’t a Hemangioma?

·
How Should You Image a Child's Vascular Anomaly That Isn't a Hemangioma?

A 7-year-old presents to your clinic with a soft, compressible, bluish discoloration on his calf that has been present since birth. His parents report it has slowly enlarged over the past year and occasionally becomes tender after long periods of activity. It does not have the classic “strawberry” appearance of an infantile hemangioma, and its persistence and slow growth raise concern for a vascular malformation. You need to choose the best initial imaging study to characterize the lesion, guide further management, and provide the family with answers. This is a common pediatric scenario where selecting the right first step is critical for an efficient and safe diagnostic pathway. According to the American College of Radiology (ACR) Appropriateness Criteria, an Ultrasound (US) of the area of interest is Usually Appropriate as the initial imaging modality.

Who Fits This Clinical Scenario?

This guidance applies specifically to a child presenting with clinical signs or symptoms of a soft tissue vascular anomaly where the diagnosis of a typical infantile hemangioma is not suspected. The key inclusion criteria are:

  • Patient Age: Child (i.e., not an infant in the first few months of life where infantile hemangioma is most common).
  • Clinical Presentation: A soft tissue mass, discoloration, swelling, or pain suggestive of a vascular origin. The lesion is often congenital (present at birth) and demonstrates slow, proportional growth with the child, or may expand due to trauma, puberty, or infection.
  • Exclusion of Infantile Hemangioma: The lesion’s history and appearance are inconsistent with a classic infantile hemangioma, which typically appears weeks after birth, undergoes a rapid proliferation phase, and then slowly involutes.

This workflow is distinct from other clinical situations. This article does not apply if:

  • The patient is an infant with a classic “strawberry” mark highly suggestive of an infantile hemangioma.
  • The goal is to screen an infant with multiple cutaneous hemangiomas for visceral involvement.
  • An ultrasound has already been performed and the question is the next imaging study for a suspected vascular malformation.

Correctly identifying your patient’s scenario ensures the most appropriate imaging is selected from the outset, avoiding unnecessary tests and delays in diagnosis.

What Diagnoses Are You Working Up in This Scenario?

When a child presents with a suspected vascular anomaly that is not a typical infantile hemangioma, the differential diagnosis is broad. The primary goal of initial imaging is to differentiate between various types of vascular malformations and other vascular tumors or soft tissue masses.

Vascular Malformations are the most common consideration in this setting. These are congenital, structural errors in vascular development that are present at birth and grow commensurately with the child. They are classified by the primary vessel type involved. Slow-flow malformations, such as venous malformations (VMs) and lymphatic malformations (LMs), are most prevalent. VMs are often soft, compressible, and blue-tinged, while LMs can present as cystic masses (macrocystic) or more infiltrative lesions (microcystic). Fast-flow malformations, like arteriovenous malformations (AVMs), are less common but more consequential, often presenting as a warm, pulsatile mass with an audible bruit or palpable thrill.

Other Vascular Tumors, while rarer, must be considered. These include kaposiform hemangioendothelioma (KHE) and tufted angioma, which are locally aggressive tumors that can be associated with profound thrombocytopenia (Kasabach-Merritt phenomenon). Unlike malformations, these are true neoplasms with cellular proliferation.

Non-Vascular Soft Tissue Masses can sometimes mimic vascular anomalies. The differential includes benign lesions like lipomas or neurofibromas, as well as malignant tumors such as rhabdomyosarcoma. While a congenital history and slow growth make malignancy less likely, it remains a critical diagnosis to exclude, and imaging provides essential clues to tissue composition.

Why Is Ultrasound the Recommended Initial Study for This Presentation?

The ACR designates US area of interest and US duplex Doppler area of interest as Usually Appropriate for the initial evaluation of a suspected vascular anomaly in a child. This recommendation is based on the modality’s high diagnostic utility, safety profile, and accessibility.

Ultrasound provides an excellent initial characterization of soft tissue lesions without using ionizing radiation (Pediatric Radiation Level: O, 0 mSv). Grayscale imaging can determine the lesion’s size, depth, and composition (e.g., solid, cystic, mixed) and its relationship to adjacent muscles, nerves, and vessels. The addition of color and spectral Duplex Doppler is crucial. It allows for the assessment of blood flow, which is the key step in differentiating between slow-flow (venous, lymphatic) and fast-flow (arteriovenous) malformations. A slow-flow lesion will show minimal or monophasic venous flow, whereas a fast-flow AVM will demonstrate a tangle of vessels with high-velocity, low-resistance arterial flow and pulsatile venous flow.

In contrast, other imaging modalities are rated lower for this initial step:

  • Computed Tomography (CT) with or without contrast is rated Usually not appropriate. The primary reason is the exposure to ionizing radiation (Pediatric Radiation Level: Varies), which should be minimized in children whenever possible (the ALARA principle). Furthermore, Magnetic Resonance Imaging (MRI) offers superior soft tissue contrast for characterizing these lesions without any radiation dose.
  • Radiography (X-ray) is also rated Usually not appropriate. It has a very limited role, as it cannot visualize the soft tissue components of the anomaly. Its only potential utility is in identifying phleboliths (calcified thrombi), which are pathognomonic for venous malformations, but their absence does not exclude the diagnosis.

While MRI/MRA without and with IV contrast is also rated Usually Appropriate, it is typically reserved as a second-line or problem-solving tool after an initial ultrasound. US is often sufficient for diagnosis and can guide whether the comprehensive anatomical detail provided by MRI is necessary for treatment planning, especially for larger, deeper, or more complex lesions. Starting with US is a more efficient, cost-effective, and patient-friendly approach.

What’s Next After Ultrasound? Downstream Workflow

The results of the initial ultrasound will guide the subsequent clinical and imaging pathway. The goal is to move from initial detection to a definitive diagnosis and a clear plan for management, which often involves a multidisciplinary vascular anomalies team.

  • If the US suggests a slow-flow malformation (e.g., venous or lymphatic): The next step is often a comprehensive MRI of the area of interest without and with IV contrast. While US can make the diagnosis, MRI is superior for defining the full anatomic extent of the lesion, its involvement of adjacent structures (muscle, nerve, bone), and its connection to the deep venous system. This detailed mapping is essential for planning treatment, such as sclerotherapy or surgical resection. This workflow aligns with the neighboring ACR scenario, “Child. Ultrasound features raise suspicion for vascular malformation. Next imaging study.”
  • If the US suggests a fast-flow malformation (e.g., AVM): This finding requires urgent, detailed characterization. An MRA and MRV of the area of interest without and with IV contrast is the next logical step. This will delineate the feeding arteries, the central nidus, and the draining veins, which is critical information for planning endovascular embolization.
  • If the US is indeterminate or suspicious for a solid tumor: An MRI without and with contrast is necessary for further tissue characterization. If malignancy is a concern, this will be followed by a biopsy.
  • If the US is negative: If a strong clinical suspicion remains despite a negative ultrasound, the lesion may be very subtle or located in a region difficult to visualize with US. A clinical re-evaluation is warranted, and an MRI may be considered if symptoms persist.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup of pediatric vascular anomalies requires careful attention to detail to avoid common missteps. Be mindful of these potential pitfalls:

  • Incomplete Ultrasound: Failing to perform a complete Duplex Doppler evaluation can lead to misclassification of a lesion. A high-flow AVM could be mistaken for a slow-flow malformation or solid mass if flow is not assessed.
  • Underestimating Lesion Extent: Relying solely on ultrasound for large, deep, or infiltrative lesions can lead to an underestimation of their true extent. MRI is crucial for pre-treatment planning in these cases.
  • Prematurely Ordering CT: Defaulting to CT exposes the child to unnecessary ionizing radiation when radiation-free alternatives like US and MRI provide equivalent or superior diagnostic information for this indication.
  • Misidentifying a Tumor as a Malformation: While rare, certain vascular tumors can mimic malformations. Rapid growth, unusual firmness, or associated systemic symptoms (like thrombocytopenia) are red flags.

If you encounter a rapidly growing lesion, severe pain, bleeding, ulceration, or signs of a consumptive coagulopathy, it is critical to escalate care immediately to a specialized pediatric center with a multidisciplinary vascular anomalies team.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to this topic, or to explore the technical details of the recommended imaging studies, the following resources are available.

Frequently Asked Questions

Why not order an MRI as the very first study for a suspected vascular anomaly?

While MRI is an excellent tool, ultrasound is often preferred for the initial evaluation because it is less expensive, more widely available, does not require sedation in young children, and uses no ionizing radiation. US with Doppler is highly effective at confirming the presence of a vascular lesion and classifying it as slow-flow or fast-flow, which is the most critical first step in directing further management.

What is the key clinical difference between a vascular malformation and an infantile hemangioma?

The primary difference is their natural history. Infantile hemangiomas are typically absent at birth, appear in the first few weeks of life, grow rapidly for several months (proliferative phase), and then slowly shrink over years (involuting phase). Vascular malformations are present at birth (though may not be immediately apparent), grow proportionally with the child, and never involute.

Does the child need intravenous contrast for the initial ultrasound?

Standard ultrasound with Duplex Doppler does not require IV contrast. The ACR panel notes that US with IV contrast (using microbubble contrast agents) is a technique that ‘May be appropriate’ but with disagreement among experts. For most initial diagnostic purposes, a non-contrast Duplex ultrasound is sufficient to characterize the lesion and its flow dynamics.

Is there any role for a plain radiograph (X-ray) in this workup?

The role is very limited, which is why it is rated ‘Usually not appropriate.’ An X-ray cannot visualize the soft tissue anomaly itself. Its only potential utility is the detection of phleboliths, which are small calcifications within venous malformations. However, ultrasound is far more sensitive for diagnosing a venous malformation, making X-ray largely obsolete as a primary tool.

How does the workup change if the vascular anomaly is located on the face or near the airway?

Lesions in critical locations like the face, orbit, or airway demand a more comprehensive and often more urgent evaluation. While ultrasound may still be a useful first step, there is a much lower threshold to proceed directly to MRI/MRA to fully define the anatomy and its impact on vital structures. These cases should always be managed by a multidisciplinary team with expertise in pediatric vascular anomalies.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026